Materials & Resources » Chemicals | Boai NKY Pharmaceuticals Ltd.

Boai NKY Pharmaceuticals Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
20,165.10
30,117.90
56,985.70
80,223.30
92,645.40
90,581.60
Depreciation, Depletion & Amortization
9,677.90
19,306.00
24,314.90
32,400.40
36,408.90
40,946.40
Other Funds
5,985.30
1,300.00
176,669.70
3,321.00
3,687.00
49,622.60
Funds from Operations
30,318.10
49,915.00
89,121.70
131,093.80
140,244.50
177,136.20
Changes in Working Capital
7,141.50
3,130.40
16,530.60
10,862.80
90,684.20
127,900.80
Net Operating Cash Flow
23,176.60
46,784.60
72,591.00
120,231.00
49,560.20
49,235.40
Capital Expenditures
35,472.50
47,106.60
40,476.60
48,468.80
128,059.10
Sale of Fixed Assets & Businesses
-
-
75.00
-
71.50
Purchase/Sale of Investments
-
-
2,230.80
66,476.60
267,997.60
Net Investing Cash Flow
35,472.50
47,106.60
42,632.40
114,945.40
396,954.50
Cash Dividends Paid - Total
-
6,912.00
11,520.00
17,048.20
16,898.20
Issuance/Reduction of Debt, Net
5,000.00
25,000.00
25,000.00
3,900.00
534,650.00
Net Financing Cash Flow
10,985.30
19,388.00
140,149.70
16,469.30
514,064.80
Net Change in Cash
23,999.50
18,823.30
171,188.00
11,034.40
166,098.80
Free Cash Flow
12,295.90
322.10
32,114.40
71,762.20
78,498.90
Deferred Taxes & Investment Tax Credit
136.20
695.40
2,729.40
169.60
1,697.50
4,014.40
Net Assets from Acquisitions
-
-
-
-
969.20
Exchange Rate Effect
718.40
242.70
1,079.70
149.30
571.80

About Boai NKY Pharmaceuticals

View Profile
Address
No. 1888 Wenhua (East Section) Road
Jiaozuo Henan 454450
China
Employees -
Website http://www.boai-nky.com
Updated 07/08/2019
NKY Medical Holdings Ltd. engages in the manufacture of polymers for pharmaceuticals, personal care and household industries. Its products include KoVidone K, PolyKoVidone, KoVidone I, KoVidone VA64, OraRez, PVM/MA-AN, PVM/MA-Diacid, PVM/MA-MS, WhiVidone. The company was founded on March 13, 2003 and is headquartered in Jiaozuo, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.